A general explainer post contrasts the receptor activity of the two incretin drugs used in metabolic care. Little detail is available beyond the title.
Recap by typeshit. Post by Facebook on Facebook.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
The 1,200-person trial starts next year with MIT and Pitt researchers, funded by a $13 million Arnold Ventures grant, and will also track housing and jobs.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
A piece argues drugs such as Ozempic are driving a health problem that gets little attention. Details beyond the title are thin.
A look at how GHK-Cu helps scientists study metal coordination and its possible uses in biotechnology and materials work.
Loading…